explore -WSS

explore

author：Wikipedia 2025-09-29 16:25:40 - browse：36

An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Pregnancy discrimination could be enabled by AI

knowledge

WSS

All of Us, NIH's precision medicine initiative, gets a big boost

FDA approves world's first CRISPR

CMS should re

Roche to buy Carmot Therapeutics, developer of obesity drugs

Why sickle cell disease is getting the first CRISPR treatment

Radiology is caught between AI's potential and concern for patients

entertainment

explore

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The woman behind the Dana Farber

Virginia high school admissions case could be legal follow

Roche to buy Carmot Therapeutics, developer of obesity drugs

The cancer drug shortage isn’t new — and neither are the solutions

After sickle

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Psychedelics group wrestles with new pharma identity

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

focus

Medicare proceeds with plan to claw back hospital funds

AI models in health care face new federal disclosure requirements

Spinal cord stimulation reduces pain in amputees, study finds

After Sarepta trial failure, Duchenne families brace for more debate

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Inari Medical to buy amputation prevention company LimFlow

entertainment

entertainment

knowledge

leisure time